Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality

Alexander T. Cohen, Giancarlo Agnelli, Frederick A. Anderson, Juan I. Arcelus, David Bergqvist, Josef G. Brecht, Ian A. Greer, John A. Heit, Julia L. Hutchinson, Ajay K. Kakkar, Dominique Mottier, Emmanuel Oger, Meyer Michel Samama, Michael Spannagl

Research output: Contribution to journalArticle

965 Scopus citations

Abstract

Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at death, and there is a lack of routine postmortem examinations. These factors are thought to result in marked underestimates of VTE incidence. The objective of our study was to estimate the total burden of VTE within the European Union (EU) per annum. An epidemiological model was constructed to estimate the number of community- and hospital-acquired incidents and recurrent cases (attack rate) of non-fatal VTE and VTE-related deaths, as well as incident and prevalent cases of post-thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (PH) occurring in the EU per annum. Individual models were developed for six EU countries. The models were populated with data from published literature and, where necessary, expert opinions. The findings were tested using probabilistic sensitivity analyses. The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715 (404,664-538,189) cases of deep-vein thrombosis, 295,982 (242,450-360,363) cases of pulmonary embolism (PE), and 370,012 (300,193-483,108) VTE-related deaths. Of these deaths, an estimated 27,473 (7%) were diagnosed as being antemortem; 126,145 (34%) were sudden fatal PE, and 217,394 (59%) followed undiagnosed PE. Almost three-quarters of all VTE-related deaths were from hospital-acquired VTE. VTE is a major health problem in the EU, with over one million VTE events or deaths per annum in the six countries examined. Given the availability of effective VTE prophylaxis, many of these events and deaths could have been prevented. These results have important implications for the allocation of healthcare resources.

Original languageEnglish (US)
Pages (from-to)756-764
Number of pages9
JournalThrombosis and Haemostasis
Volume98
Issue number4
DOIs
StatePublished - Oct 2007

Keywords

  • Deep-vein thrombosis
  • Post-thrombotic syndrome
  • Pulmonary embolism
  • Pulmonary hypertension
  • VTE prophylaxis
  • Venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality'. Together they form a unique fingerprint.

  • Cite this

    Cohen, A. T., Agnelli, G., Anderson, F. A., Arcelus, J. I., Bergqvist, D., Brecht, J. G., Greer, I. A., Heit, J. A., Hutchinson, J. L., Kakkar, A. K., Mottier, D., Oger, E., Samama, M. M., & Spannagl, M. (2007). Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality. Thrombosis and Haemostasis, 98(4), 756-764. https://doi.org/10.1160/TH07-03-0212